Teves, Zaimin Yaz .

HRN: 21-67-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/07/2022
07/14/2022
IVT
137 Mg
Q 8 H
Amoebiasis
Waiting Final Action 
07/08/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/08/2022
07/15/2022
ORAL
5.5ml
Tid
Ameobiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: